Overview
Biotechnological processes are under development that enable microbes to synthesize proteins and vitamin B9 (folate) suitable for human consumption. This production method utilizes fundamental chemical constituents, specifically carbon dioxide (CO₂), hydrogen, and oxygen, as inputs. The approach circumvents conventional agricultural and livestock farming practices, offering an alternative production pathway. These processes, often termed 'power-to-protein' and 'power-to-vitamin', necessitate an energy input for their operation. The current advancements indicate that these microbial production methods can achieve commercially viable pricing for the resulting protein and vitamin B9.
Research Context
The development of these biotechnological systems addresses the production of essential nutritional components. The focus is on creating protein and vitamin B9, which are targeted for human consumption. The core mechanism involves harnessing microbes for their metabolic capabilities. This approach is positioned as a departure from established food production systems, namely livestock farming and agriculture, by offering a synthetic biological route. The necessity of energy input categorizes these processes within the 'power-to-protein' and 'power-to-vitamin' nomenclature, highlighting their reliance on external energy sources to drive the conversion of chemical inputs into desired nutritional outputs.
Approach
The research involves developing biotechnological processes. These processes leverage microbes to facilitate the conversion of specific chemical inputs into human-consumable products. The identified inputs are carbon dioxide, hydrogen, and oxygen. The outputs of these microbial conversions are proteins and vitamin B9. A key aspect of the development is ensuring the commercial viability of the production costs. This focus on cost-effectiveness is integral to the potential application and scalability of these biotechnological methods for producing nutritional components.
Findings
Research has indicated that microbes can be engineered or selected to produce protein and vitamin B9 for human consumption. This production occurs using basic chemical ingredients: carbon dioxide, hydrogen, and oxygen. A significant finding is that the cost efficiency of these biotechnological processes can reach commercially viable levels. This suggests that the 'power-to-protein' and 'power-to-vitamin' methods are not only technically feasible but also economically competitive in producing these nutritional components.
Why This Matters
The development of biotechnological processes that enable microbes to produce protein and vitamin B9 from CO₂, hydrogen, and oxygen at commercially viable prices matters because it provides an alternative to traditional livestock farming and agriculture for generating these human nutritional components.